BTIG Initiates Coverage of Hyperfine, Inc. (HYPR) With a Bullish Outlook

Hyperfine, Inc. (NASDAQ:HYPR) is one of the top 10 hot penny stocks to buy now. BTIG initiated coverage of Hyperfine, Inc. (NASDAQ:HYPR) with a Buy rating on April 29, setting a price target of $2 and telling investors in a research note that the company’s Swoop System enables point-of-care brain MRI at the bedside, expanding access to MRI imaging through the elimination of the need for a shielded room, specialized staff, and patient transport. It further stated that the next-generation Swoop V2, cleared in May 2025, paired with the 11th-generation Optive AI software release in December 2025, offers a significant step forward in image quality and clinical utility.

The rating update came the same day Hyperfine, Inc. (NASDAQ:HYPR) announced that AIIMS New Delhi has initiated clinical use of the Swoop® portable MRI system, making it the first hospital in India to deploy bedside MRI for routine clinical use. This marks a significant milestone for neurological care across the country.

Hyperfine, Inc. (NASDAQ:HYPR) is a medical device development company involved in the provision of imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company also develops imaging of health conditions through its Swoop portable magnetic resonance imaging.

While we acknowledge the risk and potential of HYPR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than HYPR and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.